{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:25:48Z","timestamp":1783423548790,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Center for Clinical and Translational Science","award":["5UL1 RR025777"],"award-info":[{"award-number":["5UL1 RR025777"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08 NS060948"],"award-info":[{"award-number":["K08 NS060948"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuroscience.2015.08.042","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T23:59:17Z","timestamp":1440460757000},"page":"73-82","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3\u03b8 overexpression promotes recovery in the MPTP mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"307","author":[{"given":"H.","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lavalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Yacoubian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2015.08.042_b0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ana.10621","article-title":"Specification of 14-3-3 proteins in Lewy bodies","volume":"54","author":"Berg","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0010","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1161\/01.RES.0000260805.99076.22","article-title":"Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT\/enhancer binding protein-beta","volume":"100","author":"Brunelli","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s12031-013-0086-5","article-title":"Alpha-Synuclein overexpression represses 14-3-3theta transcription","volume":"51","author":"Ding","year":"2013","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0020","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1242\/jcs.01171","article-title":"Unlocking the code of 14-3-3","volume":"117","author":"Dougherty","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20100784","article-title":"Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)\/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization","volume":"430","author":"Dzamko","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","article-title":"Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment","volume":"95","author":"Elsworth","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0035","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","article-title":"High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer","volume":"97","author":"Ferguson","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0040","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2009.06072.x","article-title":"Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions","volume":"109","author":"Gibrat","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(85)90482-0","article-title":"Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources","volume":"117","author":"Heikkila","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0050","doi-asserted-by":"crossref","first-page":"15673","DOI":"10.1021\/bi9914255","article-title":"Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins","volume":"38","author":"Itagaki","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2009.05.033","article-title":"SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner","volume":"66","author":"Kajiwara","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","article-title":"14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains","volume":"61","author":"Kawamoto","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0070","doi-asserted-by":"crossref","first-page":"e17153","DOI":"10.1371\/journal.pone.0017153","article-title":"Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson\u2019s disease","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.ATV.0000223875.14120.93","article-title":"Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation","volume":"26","author":"Liou","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0080","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/BJ20031332","article-title":"Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes","volume":"381","author":"Mackintosh","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.abb.2013.10.012","article-title":"14-3-3epsilon and NAV2 interact to regulate neurite outgrowth and axon elongation","volume":"540","author":"Marzinke","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0095","doi-asserted-by":"crossref","first-page":"45193","DOI":"10.1074\/jbc.M105971200","article-title":"14-3-3 proteins mediate an essential anti-apoptotic signal","volume":"276","author":"Masters","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0100","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1523\/JNEUROSCI.4204-03.2004","article-title":"Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra","volume":"24","author":"Miller","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"Nichols","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0110","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"Alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/cbt.2.3.364","article-title":"Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells","volume":"2","author":"Parker","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0120","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","article-title":"Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage","volume":"102","author":"Perier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0125","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1093\/hmg\/ddu275","article-title":"The chaperone-like protein 14-3-3eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity","volume":"23","author":"Plotegher","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.semcancer.2006.03.003","article-title":"Dynamic 14-3-3\/client protein interactions integrate survival and apoptotic pathways","volume":"16","author":"Porter","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0135","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1523\/JNEUROSCI.4393-13.2014","article-title":"14-3-3 proteins are required for hippocampal long-term potentiation and associative learning and memory","volume":"34","author":"Qiao","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.emboj.7600774","article-title":"14-3-3eta is a novel regulator of parkin ubiquitin ligase","volume":"25","author":"Sato","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0145","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0155","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson\u2019s disease pathology","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2015.02.032","article-title":"Increased 14-3-3 phosphorylation observed in Parkinson\u2019s disease reduces neuroprotective potential of 14-3-3 proteins","volume":"79","author":"Slone","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0165","doi-asserted-by":"crossref","first-page":"e21720","DOI":"10.1371\/journal.pone.0021720","article-title":"14-3-3theta protects against neurotoxicity in a cellular Parkinson\u2019s disease model through inhibition of the apoptotic factor bax","volume":"6","author":"Slone","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","article-title":"The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice","volume":"129","author":"Sonsalla","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0175","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2010.02.008","article-title":"Genes regulated in MPTP-treated macaques and human Parkinson\u2019s disease suggest a common signature in prefrontal cortex","volume":"38","author":"Storvik","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1169","article-title":"14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome","volume":"34","author":"Toyo-oka","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0195","doi-asserted-by":"crossref","first-page":"e13367","DOI":"10.1371\/journal.pone.0013367","article-title":"DEGAS: de novo discovery of dysregulated pathways in human diseases","volume":"5","author":"Ulitsky","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0200","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0205","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1074\/jbc.M901310200","article-title":"14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0210","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.108.812537","article-title":"Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3epsilon upregulation","volume":"119","author":"Wu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0215","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nbd.2007.11.008","article-title":"Transcriptional dysregulation in a transgenic model of Parkinson disease","volume":"29","author":"Yacoubian","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0220","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/cddis.2009.4","article-title":"Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson\u2019s disease","volume":"1","author":"Yacoubian","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0225","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/dneu.20955","article-title":"14-3-3 proteins regulate retinal axon growth by modulating ADF\/cofilin activity","volume":"72","author":"Yoon","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","article-title":"Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms","volume":"137B","author":"Zhang","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.neuroscience.2015.08.042_b0235","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1074\/jbc.M211907200","article-title":"Monomeric 14-3-3 protein is sufficient to modulate the activity of the Drosophila slowpoke calcium-dependent potassium channel","volume":"278","author":"Zhou","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215007745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215007745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:30:01Z","timestamp":1718044201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452215007745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":47,"alternative-id":["S0306452215007745"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2015.08.042","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}